Clinical Trials Directory

Trials / Completed

CompletedNCT04974034

Movement Disorders Analysis Using a Deep Learning Approach

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Hospital Avicenne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Bradykinesia is a key parkinsonian feature yet subjectively assessed by the MDS-UPDRS score, making reproducible measurements and follow-up challenging. In a Movement Disorder Unit, the investigators acquired a large database of videos showing parkinsonian patients performing Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III protocols. Using a Deep Learning approach on these videos, the investigators aimed to develop a tool to compute an objective score of bradykinesia from the three upper limb tests described in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III.

Conditions

Timeline

Start date
2019-06-01
Primary completion
2020-11-18
Completion
2020-12-31
First posted
2021-07-23
Last updated
2021-07-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04974034. Inclusion in this directory is not an endorsement.